Epizyme Gets $90M in Epigenetics Partnership with Celgene

Arlene Weintraub Cambridge, MA-based Epizyme said today that it has formed a strategic partnership with an international subsidiary of Summit, NJ-based Celgene (NASDAQ: CELG). The two companies will…
Read the full story: Xconomy